Cardiomyocyte Degeneration With Calpain Deficiency Reveals a Critical Role in Protein Homeostasis

Regulating the balance between synthesis and proteasomal degradation of cellular proteins is essential for tissue growth and maintenance, but the critical pathways regulating protein ubiquitination and degradation are incompletely defined. Although participation of calpain calcium-activated proteases in post-necrotic myocardial autolysis is well characterized, their importance in homeostatic turnover of normal cardiac tissue is controversial. Hence, we evaluated the consequences of physiologic calpain (calcium-activated protease) activity in cultured cardiomyocytes and unstressed mouse hearts. Comparison of in vitro proteolytic activities of cardiac-expressed calpains 1 and 2 revealed calpain 1, but not calpain 2, activity at physiological calcium concentrations. Physiological calpain 1 activation was evident in adenoviral transfected cultured cardiomyocytes as proteolysis of specific substrates, generally increased protein ubiquitination, and accelerated protein turnover, that were each inhibited by coexpression of the inhibitor protein calpastatin. Conditional forced expression of calpain 1, but not calpain 2, in mouse hearts demonstrated substrate-specific proteolytic activity under basal conditions, with hyperubiquitination of cardiac proteins and increased 26S proteasome activity. Loss of myocardial calpain activity by forced expression of calpastatin diminished ubiquitination of 1 or more specific myocardial proteins, without affecting overall ubiquitination or proteasome activity, and resulted in a progressive dilated cardiomyopathy characterized by accumulation of intracellular protein aggregates, formation of autophagosomes, and degeneration of sarcomeres. Thus, calpain 1 is upstream of, and necessary for, ubiquitination and proteasomal degradation of a subset of myocardial proteins whose abnormal accumulation produces autophagosomes and degeneration of cardiomyocytes with functional decompensation.

[1]  G. Sommer,et al.  Reference , 2008 .

[2]  S. Vatner,et al.  Activation of the Cardiac Proteasome During Pressure Overload Promotes Ventricular Hypertrophy , 2006, Circulation.

[3]  C. Patterson,et al.  Into the heart: the emerging role of the ubiquitin-proteasome system. , 2006, Journal of molecular and cellular cardiology.

[4]  C. Tsai,et al.  Purification and Characterization , 2006 .

[5]  J. Papp,et al.  Calpain-1-sensitive myofibrillar proteins of the human myocardium , 2005, Molecular and Cellular Biochemistry.

[6]  E. Kudryashova,et al.  Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2005, Human molecular genetics.

[7]  O. Ritter,et al.  Targeted Proteolysis Sustains Calcineurin Activation , 2005, Circulation.

[8]  G. Dorn,et al.  Physiological Growth Synergizes With Pathological Genes in Experimental Cardiomyopathy , 2004, Circulation research.

[9]  A. Goldberg,et al.  Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[10]  M. Zatz,et al.  The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A , 2003, Journal of clinical pathology.

[11]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[12]  Q. Liang,et al.  Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.

[13]  Ken-ichi Yoshida,et al.  Phosphoinositide 3-kinase accelerates calpain-dependent proteolysis of fodrin during hypoxic cell death. , 2002, Journal of biochemistry.

[14]  E. Sztul,et al.  Hassles with Taking Out the Garbage: Aggravating Aggresomes , 2002, Traffic.

[15]  H. Hatch,et al.  Casein zymography of calpains using a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-imidazole buffer. , 2002, Analytical biochemistry.

[16]  S. Sandmann,et al.  Activity profile of calpains I and II in chronically infarcted rat myocardium – influence of the calpain inhibitor CAL 9961 , 2002, British journal of pharmacology.

[17]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[18]  John Calvin Reed,et al.  Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion* , 2001, The Journal of Biological Chemistry.

[19]  M. Hori,et al.  Intracellular calcium level required for calpain activation in a single myocardial cell. , 2001, Journal of molecular and cellular cardiology.

[20]  Changlian Zhu,et al.  Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.

[21]  J. Fischer,et al.  Muscle Cachexia: Current Concepts of Intracellular Mechanisms and Molecular Regulation , 2001, Annals of surgery.

[22]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[23]  J. Beckmann,et al.  Calpainopathy-a survey of mutations and polymorphisms. , 1999, American journal of human genetics.

[24]  M. Matsuzaki,et al.  Calpain inhibitor-1 reduces infarct size and DNA fragmentation of myocardium in ischemic/reperfused rat heart. , 1999, Journal of cardiovascular pharmacology.

[25]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[26]  J. Beckmann,et al.  Clinical, pathological, and genetic features of limb‐girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families , 1998, Muscle & nerve.

[27]  S. Schreiber,et al.  Lactacystin, Proteasome Function, and Cell Fate* , 1998, The Journal of Biological Chemistry.

[28]  Wolfgang Baumeister,et al.  The Proteasome: Paradigm of a Self-Compartmentalizing Protease , 1998, Cell.

[29]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[30]  D. Atar,et al.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.

[31]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[32]  A. Goldberg,et al.  Importance of the ATP-Ubiquitin-Proteasome Pathway in the Degradation of Soluble and Myofibrillar Proteins in Rabbit Muscle Extracts* , 1996, The Journal of Biological Chemistry.

[33]  A. Goldberg Functions of the proteasome: the lysis at the end of the tunnel. , 1995, Science.

[34]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[35]  M. Fujiwara,et al.  Calpain is implicated in rat myocardial injury after ischemia or reperfusion. , 1994, Japanese circulation journal.

[36]  K. Suzuki,et al.  Positive regulation of mu-calpain action by polyphosphoinositides. , 1992, The Journal of biological chemistry.

[37]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.

[38]  J. Lowe,et al.  Ubiquitin in health and disease. , 1991, Biochimica et biophysica acta.

[39]  D. E. Goll,et al.  The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain). , 1989, The Journal of biological chemistry.

[40]  Y. Nishizuka,et al.  Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). , 1989, The Journal of biological chemistry.

[41]  P. Traub,et al.  Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins , 1983, Molecular and cellular biology.

[42]  K. Imahori,et al.  Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization. , 1978, Journal of biochemistry.

[43]  G. Dorn,et al.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Clark,et al.  Inappropriate ubiquitin conjugation: a proposed mechanism contributing to heart failure. , 1997, Cardiovascular research.

[45]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[46]  K. Suzuki,et al.  Proteolysis of protein kinase C by calpain: effect of acidic phospholipids. , 1991, Biomedica biochimica acta.

[47]  M. Maki,et al.  Calpastatins: biochemical and molecular biological studies. , 1991, Biomedica biochimica acta.

[48]  B. Nadal-Ginard,et al.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.